Glucuronosyltransferase

From Citizendium
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In biochemistry, glucuronosyltransferase, also called UDP-glucuronosyltransferase, is "a family of enzymes accepting a wide range of substrates, including phenols, alcohols, amines, and fatty acids. They function as drug-metabolizing enzymes that catalyze the conjugation of UDPglucuronic acid to a variety of endogenous and exogenous compounds."[1]

Mutation in the UDP-glycuronosyltransferase gene cause Gilbert Syndrome[2] and Crigler-Najjar Syndrome types I[3] and II[4].

Anti-liver kidney microsome Type 3 (LKM3) autoantibodies may be present in chonic hepatitis D,[5] autoimmune hepatitis and chronic active hepatitis.[6]

Glucuronosyltransferase is part of the phase II drug metabolism of morphine and acetaminophen.[7]

Some drug interactions may be due to glucuronosyltransferase.[8]

References

  1. Anonymous (2024), Glucuronosyltransferase (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. Online Mendelian Inheritance in Man, OMIM®. Johns Hopkins University, Baltimore, MD. MIM Number: 143500. World Wide Web URL: http://omim.org/.
  3. Online Mendelian Inheritance in Man, OMIM®. Johns Hopkins University, Baltimore, MD. MIM Number: 218800. World Wide Web URL: http://omim.org/.
  4. Online Mendelian Inheritance in Man, OMIM®. Johns Hopkins University, Baltimore, MD. MIM Number: 606785. World Wide Web URL: http://omim.org/.
  5. Obermayer-Straub P, Manns MP (1996). "Cytochromes P450 and UDP-glucuronosyl-transferases as hepatocellular autoantigens.". Baillieres Clin Gastroenterol 10 (3): 501-32. PMID 8905121.
  6. Fabien N, Desbos A, Bienvenu J, Magdalou J (2004). "Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis.". Autoimmun Rev 3 (1): 1-9. DOI:10.1016/S1568-9972(03)00051-X. PMID 14871643. Research Blogging.
  7. de Wildt SN, Kearns GL, Leeder JS, van den Anker JN (1999). "Glucuronidation in humans. Pharmacogenetic and developmental aspects.". Clin Pharmacokinet 36 (6): 439-52. PMID 10427468.
  8. Kiang TK, Ensom MH, Chang TK (2005). "UDP-glucuronosyltransferases and clinical drug-drug interactions.". Pharmacol Ther 106 (1): 97-132. DOI:10.1016/j.pharmthera.2004.10.013. PMID 15781124. Research Blogging.